Back to Programme

Healthy Aging: Active Longevity

February, 13
12:00–13:30
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies
World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
An aging population is inevitably accompanied by an increase in the prevalence of chronic non-communicable diseases and geriatric syndromes, as well as a boost in the proportion of elderly people in the population with reduced functionality and dependent on outside help. In this regard, the goal of achieving healthy active longevity is becoming particularly urgent. Slowing down aging may be 10 times more effective at prolonging a healthy life than preventing individual age-associated diseases. The paradigm of modern medicine is how to develop and introduce active longevity technologies using our understanding of the aging process. Thus, future technologies utilized to address active longevity will be a synthesis of modern organizational solutions to prevent and diagnose diseases at an early stage, which include the latest approaches toward treating diseases and technologies that make it possible to manage aging by carrying out truly personalized prevention and treatment. Ultimately, the introduction of these technologies in the near future will result in the delaying of the age at which diseases develop and in the extension of the period of healthy life. What technologies for the prevention and treatment of cognitive impairment are successfully being used now and will appear in the near future? What modern technologies are being used today to reduce mortality from cardiovascular diseases in different age groups? What innovative technologies for preventing premature aging are the most promising? What system of measures is most effective for maintaining one’s health and active longevity?
Moderator:
Alexey Moskalev
Director of the Research Institute of Aging Biology, N.I. Lobachevsky National Research Nizhny Novgorod State University
Panellists:
David Areshidze
Head of the Laboratory of Cell Pathology, Academician B.V. Petrovsky Russian Scientific Center for Surgery
Oksana Drapkina
Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
Vladimir Zhuikov
Executive Director, Investment Department, Russian Direct Investment Fund
Kamila Zarubina
Vice President, Executive Director of the Cluster of Biological and Medical Technologies, Skolkovo Foundation
Inna Reshetova
Chief Physician, Clinic of Preventive Medicine, Academician B.V. Petrovsky Russian Scientific Center for Surgery
Gennady Suhih
Director, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Olga Tkacheva
Director of the Russian Gerontological Research and Clinical Center, Research Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University; Chief Freelance Specialist Geriatrician of the Ministry of Health of the Russian Federation
Svetlana Shport
General Director, Serbsky National Medical Research Centre for Psychiatry and Narcology of Ministry of Heath of the Russian Federation; Chief freelance psychiatrist of the Ministry of Health of the Russian Federation
Sergey Yudin
Director, Center for Strategic Planning and Management of Medical and Biological Health Risks of the Federal Medical and Biological Agency of Russia
трансляция